CAUTI Prevention Urology Products Market to Reach US$ 5.90 Billion by 2033 Driven by Rising Hospital-Acquired Infection Concerns, Growing Catheter Usage, and Advancements in Antimicrobial Technologies

The CAUTI Prevention Urology Products Market reached US$ 3.30 billion in 2025 and is expected to reach US$ 5.90 billion by 2033, growing at a CAGR of 7.5% during the forecast period 2026-2033.

Growth is driven by the increasing prevalence of catheter associated urinary tract infections (CAUTIs) and the rising focus on infection prevention and patient safety in healthcare settings. CAUTI prevention urology products, including antimicrobial catheters, closed drainage systems, and infection control accessories, play a crucial role in reducing hospital acquired infections and improving clinical outcomes. Additionally, growing hospital admissions, expanding geriatric population, and increased use of indwelling catheters are accelerating market demand. Supportive healthcare policies, advancements in antimicrobial coatings and materials, and heightened awareness of infection control protocols are further fueling the global growth of the CAUTI prevention urology products market.

Download your exclusive sample report(corporate email gets priority access): https://www.datamintelligence.com/download-sample/cauti-prevention-urology-products-market?praneetha

✦ CAUTI Prevention Urology Products Market: Competitive Intelligence
The major global players in the market include B. Braun SE, Teleflex Incorporated, Hollister Incorporated, Coloplast, Becton, Dickinson and Company (BD), ConvaTec Group PLC, Boston Scientific Corporation, Cardinal Health, Inc., Merit Medical Systems, Inc., and Medline Industries, LP, among others.

The CAUTI (Catheter-Associated Urinary Tract Infection) Prevention Urology Products Market is driven by leading medical device manufacturers such as BD, B. Braun, Teleflex, and Coloplast, which offer a comprehensive range of urology products including indwelling and intermittent urinary catheters, closed drainage systems, external urine management devices, and catheter maintenance solutions. These products are designed to enhance patient safety, reduce infection risks, and improve clinical outcomes.

These companies' complementary strengths include BD and B. Braun's strong global medical device portfolios, Coloplast's specialization in continence care, Teleflex's advanced catheter technologies, and ConvaTec and Hollister's expertise in ostomy and wound care are strengthening competitive positioning. Continuous investments in antimicrobial catheter technologies, infection prevention solutions, patient friendly designs, and regulatory compliant healthcare products are driving market growth amid increasing focus on hospital acquired infection reduction, rising surgical procedures, and growing healthcare infrastructure worldwide.

Ready to scale in this Market ? Connect with the right partners and unlock new growth opportunities :- https://www.datamintelligence.com/partner-identification-enquiry//cauti-prevention-urology-products-market?praneetha

✦ New Product Launches
Becton, Dickinson and Company (BD)
BD expanded its urology portfolio with advanced antimicrobial and antiseptic coated urinary catheters designed to reduce infection risk. The products focus on minimizing bacterial colonization and improving patient safety. These innovations support hospital infection control initiatives.

Coloplast A/S
Coloplast introduced next-generation intermittent catheters with hydrophilic coatings and improved ergonomic designs. The offerings enhance ease of use and reduce urethral trauma. These developments contribute to lowering the incidence of catheter-associated infections.

✦ R&D Developments
Teleflex Incorporated
Teleflex continued R&D in infection prevention technologies for urology, focusing on antimicrobial materials and closed catheter systems. The company is developing solutions that minimize contamination during catheterization. These advancements improve clinical outcomes and patient safety.

B. Braun Melsungen AG
B. Braun advanced research in sterile and closed urinary drainage systems, emphasizing infection control and usability. The company is focusing on improving product design and material safety. These developments support healthcare-associated infection reduction strategies.

✦ Technological Advancements
Antimicrobial & Antiseptic Coating Technologies
The market is witnessing strong advancements in catheter coatings that prevent bacterial adhesion and biofilm formation. These technologies significantly reduce infection risks. This enhances patient safety in long-term catheterization.

Closed System Catheterization & Infection Control Solutions
Technological progress is enabling closed urinary catheter systems that reduce exposure to external contaminants. These systems improve hygiene and reduce handling errors. This supports effective CAUTI prevention in healthcare settings.

✦ M&A / Strategic Developments
Cardinal Health, Inc.
Cardinal Health continued strategic expansions in infection prevention and urology products through partnerships and product development. The company is focusing on strengthening its healthcare solutions portfolio. These initiatives enhance its presence in clinical care markets.

Cook Medical
Cook Medical pursued strategic developments in urology devices and infection control solutions. The company is focusing on innovation and expanding its product range. This supports growth in minimally invasive and infection prevention technologies.

Request Custom Intelligence Report: https://www.datamintelligence.com/customize//cauti-prevention-urology-products-market?praneetha

✦ Market Segmentation
By Application
The market is segmented into Critical Care/ICU 20%, Long-Term Catheterized Patients 18%, Urinary Incontinence Management 14%, Acute Surgical & Perioperative Care 12%, Geriatric Care 10%, BPH & Obstructive Urology 8%, Neurogenic Bladder Disorders 7%, Post-Operative Urinary Retention 5%, Trauma & Emergency Care 3%, and CKD Patients 3%, with critical care dominating due to high catheter usage and infection risk in ICU settings.

By End-User
The market includes Hospitals 45%, Long-Term Care Facilities 20%, Home Care Settings 12%, Specialty Urology Clinics 8%, Ambulatory Surgical Centers 6%, Rehabilitation Centers 4%, Hospice & Palliative Care Centers 3%, Military & Veterans Facilities 1%, and Others 1%, with hospitals dominating due to high patient volume and advanced care infrastructure.

By Material
The market is segmented into Silicone 30%, Latex 20%, Hydrogel-Coated 15%, Silver-Based 12%, PVC 10%, Polyurethane 8%, and Antibiotic-Impregnated Materials 5%, with silicone dominating due to its biocompatibility and reduced risk of irritation and infection.

By Technology
The market includes Antimicrobial 30%, Hydrophilic 20%, Biofilm-Resistant Surfaces 18%, Drug-Eluting 12%, Closed-Loop Drainage Systems 10%, and Sensor-Enabled/Smart Catheters 10%, with antimicrobial technologies leading due to their effectiveness in reducing catheter-associated infections.

By Patient Type
The market is segmented into Adult 40%, Geriatric 30%, Long-Term Users 15%, Short-Term Users 10%, and Pediatric 5%, with adults dominating due to higher hospitalization rates and catheter usage.

✦ Regional Analysis
North America - 38% Share
North America leads with 38% share driven by strict infection control protocols, advanced healthcare systems, and high adoption of antimicrobial catheter technologies.

Europe - 25% Share
Europe holds 25% share supported by strong regulatory frameworks and focus on hospital-acquired infection prevention.

Asia-Pacific - 22% Share
Asia-Pacific accounts for 22% share due to rising healthcare investments and increasing awareness of infection control practices.

Purchase Corporate License | Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=cauti-prevention-urology-products-market?praneetha

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.